These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 10488770

  • 21. Impact of HIV type 1 subtype variation on viral RNA quantitation.
    Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R.
    AIDS Res Hum Retroviruses; 1999 Jan 20; 15(2):133-42. PubMed ID: 10029245
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).
    Amendola A, Bordi L, Angeletti C, Visco-Comandini U, Abbate I, Cappiello G, Budabbus MA, Eljhawi OA, Mehabresh MI, Girardi E, Antinori A, Ippolito G, Capobianchi MR.
    J Acquir Immune Defic Syndr; 2002 Dec 15; 31(5):488-94. PubMed ID: 12473837
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of two commercial procedures for quantification of human immunodeficiency virus type 1 RNA with respect to HIV-1 viral subtype and antiviral treatment.
    Schmid I, Arrer E, Hawranek T, Patsch W.
    Clin Lab; 2000 Dec 15; 46(7-8):355-60. PubMed ID: 10934582
    [Abstract] [Full Text] [Related]

  • 27. Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays.
    Swanson P, Holzmayer V, Huang S, Hay P, Adebiyi A, Rice P, Abravaya K, Thamm S, Devare SG, Hackett J.
    J Virol Methods; 2006 Nov 15; 137(2):184-92. PubMed ID: 16876263
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Problems in the interpretation of HIV-1 viral load assays using commercial reagents.
    O'Shea S, Chrystie I, Cranston R, Mullen J, Corbett K, Murphy G, Parry JV, De Ruiter A, Banatvala J.
    J Med Virol; 2000 Jun 15; 61(2):187-94. PubMed ID: 10797373
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.
    Antunes R, Figueiredo S, Bártolo I, Pinheiro M, Rosado L, Soares I, Lourenço H, Taveira N.
    J Clin Microbiol; 2003 Jul 15; 41(7):3361-7. PubMed ID: 12843094
    [Abstract] [Full Text] [Related]

  • 33. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.
    Yu ML, Chuang WL, Chen SC, Lin ZY, Hsieh MY, Wang LY, Chang WY.
    J Clin Pathol; 1999 Nov 15; 52(11):807-11. PubMed ID: 10690168
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5.
    Holguín A, Aracil B, Alvarez A, Barros C, Soriano V.
    J Clin Microbiol; 2001 May 15; 39(5):1850-4. PubMed ID: 11326002
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa.
    Crump JA, Scott LE, Msuya E, Morrissey AB, Kimaro EE, Shao JF, Stevens WS.
    J Virol Methods; 2009 Dec 15; 162(1-2):218-22. PubMed ID: 19729037
    [Abstract] [Full Text] [Related]

  • 36. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.
    Rouet F, Ekouevi DK, Chaix ML, Burgard M, Inwoley A, Tony TD, Danel C, Anglaret X, Leroy V, Msellati P, Dabis F, Rouzioux C.
    J Clin Microbiol; 2005 Jun 15; 43(6):2709-17. PubMed ID: 15956387
    [Abstract] [Full Text] [Related]

  • 37. HIV-1 viral load: comparative evaluation of three commercially available assays in Argentina.
    Hodara V, Monticelli A, Pampuro S, Salomón H, Jauregui Rueda H, Libonatti O.
    Acta Physiol Pharmacol Ther Latinoam; 1998 Jun 15; 48(2):107-13. PubMed ID: 9695883
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.
    Katsoulidou A, Petrodaskalaki M, Sypsa V, Papachristou E, Anastassopoulou CG, Gargalianos P, Karafoulidou A, Lazanas M, Kordossis T, Andoniadou A, Hatzakis A.
    J Virol Methods; 2006 Feb 15; 131(2):168-74. PubMed ID: 16194575
    [Abstract] [Full Text] [Related]

  • 40. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
    Drexler JF, de Souza Luna LK, Pedroso C, Pedral-Sampaio DB, Queiroz AT, Brites C, Netto EM, Drosten C.
    J Clin Microbiol; 2007 Jun 15; 45(6):2061-3. PubMed ID: 17392448
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.